Conduit Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	17	336	177	-
Market Cap Growth	312.23%	89.60%	-	-
Enterprise Value	17	333	183	1
PE Ratio	-	-627.90	-36.25	-
PB Ratio	-87.43	-735.06	-17.56	-
P/FCF Ratio	-33.40	-43.49	-78.19	-
P/OCF Ratio	-33.40	-43.49	-78.19	-
EV/EBITDA Ratio	-134.53	-1026.79	-37.50	-0.20
EV/EBIT Ratio	-134.53	-1026.79	-37.50	-0.20
EV/FCF Ratio	-33.33	-43.07	-80.88	-0.35
Debt / Equity Ratio	-0.42	-2.16	-0.60	-0.13
Debt / EBITDA Ratio	-0.64	-3.04	-1.25	-0.20
Debt / FCF Ratio	-0.16	-0.13	-2.69	-0.35
Quick Ratio	0.93	2.35	0	0
Current Ratio	1.59	3.18	0	0.05
Interest Coverage	-7.05	-1.54	-	-
Return on Equity (ROE)	45.80%	7.30%	97.00%	-
Return on Assets (ROA)	-38.00%	-11.10%	-4.80%	-
Return on Capital (ROIC)	367.85%	-996.59%	79.08%	61.10%
Earnings Yield	-13.06%	-0.16%	-2.76%	-
FCF Yield	-46.15%	-2.30%	-1.28%	-
Buyback Yield / Dilution	-14.24%	-81.30%	96.26%	-
Total Shareholder Return	-14.24%	-81.30%	96.26%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).